ApoE-Directed Therapeutics Rapidly Clear β-Amyloid and Reverse Deficits in AD Mouse Models

Cramer, Paige E., Cirrito, John R., Wesson, Daniel W., Lee, C. Y. Daniel, Karlo, J. Colleen, Zinn, Adriana E., Casali, Brad T., Restivo, Jessica L. +5 more·2012·Science

DOI 10.1126/science.1217697

Cited by (1,000)

Items 501–600 of 1,000

Interictal epileptiform discharges affect memory in an Alzheimer’s disease mouse model
Marisol Soula, Anna Maslarova, Ryan E. Harvey, Manuel Valero, Sebastian Brandner, Hajo M. Hamer, Antonio Fernández‐Ruiz, György Buzsáki · 2023 · Proceedings of the National Academy of Sciences
Lack of support for bexarotene as a treatment for Alzheimer's disease
Eugene O‘Hare, Ross Jeggo, Eun‐Mee Kim, Bridgeen Barbour, Jean‐Sébastien Walczak, Philip Palmer, Taylor Lyons, Deaglan Page, Donncha Hanna, Jolyon Meara et al. · 2015 · Neuropharmacology
A2T and A2V Aβ peptides exhibit different aggregation kinetics, primary nucleation, morphology, structure, and LTP inhibition
Brian Murray, Mirco Sorci, Joseph Rosenthal, Jennifer L. Lippens, David Isaacson, Payel Das, Daniele Fabris, Shaomin Li, Georges Belfort · 2016 · Proteins Structure Function and Bioinformatics
Soluble Gamma-secretase Modulators Attenuate Alzheimer's β-amyloid Pathology and Induce Conformational Changes in Presenilin 1
F. Raven, Joseph F. Ward, K. Zoltowska, Yu Wan, Enjana Bylykbashi, Sean J. Miller, Xunuo Shen, Se-Hoon Choi, Kevin D. Rynearson, O. Berezovska et al. · 2017 · EBioMedicine
High-Content Microfluidic Screening Platform Used To Identify σ2R/Tmem97 Binding Ligands that Reduce Age-Dependent Neurodegeneration in C. elegans SC_APP Model
Sudip Mondal, Evan Hegarty, James J. Sahn, Luisa L. Scott, Sertan Kutal Gökçe, Chris Martin, Navid Ghorashian, Praveen Satarasinghe, Sangeetha V. Iyer, Wisath Sae-Lee et al. · 2018 · ACS Chemical Neuroscience
Computational discovery and experimental verification of tyrosine kinase inhibitor pazopanib for the reversal of memory and cognitive deficits in rat model neurodegeneration
Yongliang Yang, Guohui Li, Dongyu Zhao, Haoyang Yu, Xiliang Zheng, Xiangda Peng, Xiaoe Zhang, Ting Fu, Xiaoqing Hu, Mingshan Niu et al. · 2015 · Chemical Science
Integrated approach reveals diet, APOE genotype and sex affect immune response in APP mice
Nam, Kyong Nyon, Wolfe, Cody M., Fitz, Nicholas F., Letronne, Florent, Castranio, Emilie L., Mounier, Anais, Schug, Jonathan, Lefterov, Iliya, Koldamova, Radosveta · 2018 · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease
Alzheimer’s Disease (AD) Therapeutics—2: Beyond Amyloid—Re-Defining AD and Its Causality to Discover Effective Therapeutics
Mullane, Kevin, Williams, Michael · 2018 · Biochemical Pharmacology
Retinoids and motor neuron disease: Potential role in amyotrophic lateral sclerosis
Javier Riancho, Maria Teresa Berciano, María Ruiz‐Soto, José Berciano, Gary E. Landreth, Miguel Lafarga · 2015 · Journal of the Neurological Sciences
Role of Phytoconstituents as PPAR Agonists: Implications for Neurodegenerative Disorders
Sanjay Sanjay, Anshul Sharma, Hae‐Jeung Lee · 2021 · Biomedicines
Mechanistic Insights, Treatment Paradigms, and Clinical Progress in Neurological Disorders: Current and Future Prospects
Saad Hussin Alkahtani, Norah S. AL–Johani, Saud A. Alarifi · 2023 · International Journal of Molecular Sciences
Cessation of Neoangiogenesis in Alzheimer's Disease Follows Amyloid-beta Immunization
Kaan E. Biron, Dara L. Dickstein, Rayshad Gopaul, Franz Fenninger, Wilfred Arthur Jefferies · 2013 · Scientific Reports
Repackaging FDA-approved drugs for degenerative diseases: promises and challenges
Jeffrey L. Cummings, Kate Zhong · 2014 · Expert Review of Clinical Pharmacology
Interaction between amyloidogenic proteins and biomembranes in protein misfolding diseases: Mechanisms, contributors, and therapy
Biao Cheng, Yang Li, Liang Ma, Zhuoyi Wang, Robert B. Petersen, Ling Zheng, Yuchen Chen, Kun Huang · 2018 · Biochimica et Biophysica Acta (BBA) - Biomembranes
Phototherapy via Modulation of β‐Amyloid in Combating Alzheimer's Disease
Yunhua Zhang, Chengyuan Qian, Yuncong Chen, Weijiang He, Zijian Guo · 2025 · Aggregate
Synopsis on the Linkage of Alzheimer's and Parkinson's Disease with Chronic Diseases
Nasimudeen R. Jabir, Chelapram K. Firoz, Saleh Salem Baeesa, Ghulam Md Ashraf, Suhail Akhtar, Warda Kamal, Mohammad Amjad Kamal, Shams S. M. Tabrez · 2014 · CNS Neuroscience & Therapeutics
Nuclear receptor agonist-driven modification of inflammation and amyloid pathology enhances and sustains cognitive improvements in a mouse model of Alzheimer’s disease
Brad T. Casali, Erin G. Reed-Geaghan, Gary E. Landreth · 2018 · Journal of Neuroinflammation
Retinoid X receptor agonist LG100268 modulates the immune microenvironment in preclinical breast cancer models
Ana S. Leal, Kayla Zydeck, Sarah Carapellucci, Lyndsey A. Reich, Di Zhang, Jessica A. Moerland, Michael B. Sporn, Karen T. Liby · 2019 · npj Breast Cancer
Amyloid Beta-Protein and Neural Network Dysfunction
Fernando Peña‐Ortega · 2013 · Journal of Neurodegenerative Diseases
Regulation of cyclic AMP response element‐binding protein during neuroglial interactions
LiMei Qin, Ron J. Bouchard, Subbiah Pugazhenthi · 2015 · Journal of Neurochemistry
Exploring the nexus of Alzheimer's disease and related dementias with cancer and cancer therapies: A convening of the Alzheimer's Association & Alzheimer's Drug Discovery Foundation
Heather M. Snyder, Tim A. Ahles, Stuart K. Calderwood, María C. Carrillo, Honglei Chen, Chung-Chou H. Chang, Suzanne Craft, Philip L. De Jager, Jane Ann Driver, Howard M. Fillit et al. · 2016 · Alzheimer s & Dementia
Dissecting Endoplasmic Reticulum Unfolded Protein Response (UPRER) in Managing Clandestine Modus Operandi of Alzheimer’s Disease
Safikur Rahman, Archana Ayyagari, Arif Tasleem Jan, Rinki Minakshi · 2018 · Frontiers in Aging Neuroscience
Preclinical Success against Alzheimer's Disease with an Old Drug
Frank M. LaFerla · 2012 · New England Journal of Medicine
Do Cancer Drugs Counteract Neurodegeneration? Repurposing for Alzheimer’s Disease
Fiammetta Monacelli, Michele Cea, Roberta Borghi, Patrizio R. Odetti, Alessio Nencioni · 2016 · Journal of Alzheimer s Disease
The mechanisms underlying olfactory deficits in apolipoprotein E–deficient mice: focus on olfactory epithelium and olfactory bulb
Jiajia Zhang, Caiyuan Hao, Jinxiang Jiang, Yangjian Feng, Xi Chen, Ying Zheng, Jiawei Liu, Zhilin Zhang, Cheng Long, Li Yang · 2017 · Neurobiology of Aging
Decay in Retinoic Acid Signaling in Varied Models of Alzheimer’s Disease and In-Vitro Test of Novel Retinoic Acid Receptor Ligands (RAR-Ms) to Regulate Protective Genes
Thabat Khatib, David R. Chisholm, Andrew Whiting, Bettina Platt, Peter J. A. McCaffery · 2019 · Journal of Alzheimer s Disease
Molecular Pathogenesis and Interventional Strategies for Alzheimer’s Disease: Promises and Pitfalls
Shashikala Bhute, Deepaneeta Sarmah, Aishika Datta, Pallavi Rane, Amit Shard, Avirag Goswami, Anupom Borah, Kiran Kalia, Kunjan R. Dave, Pallab Bhattacharya · 2020 · ACS Pharmacology & Translational Science
Retinoic acid receptor-targeted drugs in neurodegenerative disease
Jason Nicol Clark, Andrew Whiting, Peter J. A. McCaffery · 2020 · Expert Opinion on Drug Metabolism & Toxicology
Comprehensive Set of Tertiary Complex Structures and Palmitic Acid Binding Provide Molecular Insights into Ligand Design for RXR Isoforms
A. Chaikuad, Julius Carl Pollinger, Michael Rühl, Xiaomin Ni, Whitney Kilu, Jan Heering, Daniel Merk · 2020 · International Journal of Molecular Sciences
Erythropoietin signaling in peripheral macrophages is required for systemic β‐amyloid clearance
Xu, Lu, Li, Lei, Pan, Cai‐Long, Song, Jing‐Jing, Zhang, Chen‐Yang, Wu, Xiang‐Hui, Hu, Fan, Liu, Xue, Zhang, Zhiren, Zhang, Zhi‐Yuan · 2022 · The EMBO Journal
Targretin Improves Cognitive and Biological Markers in a Patient with Alzheimer’s Disease
Nathalie Pierrot, Renaud Lhommel, Lisa Quenon, Bernard Jimmy Hanseeuw, Laurence Dricot, Christian J. M. Sindic, Jean‐Marie Maloteaux, Jean-Noël Octavea, Adrian Ivanoiu · 2015 · Journal of Alzheimer s Disease
AβPeptide Originated from Platelets Promises New Strategy in Anti-Alzheimer’s Drug Development
Mikhail Y. Inyushin, Priscila Sanabria, Legier V. Rojas, Yuriy V. Kucheryavykh, Lilia Y. Kucheryavykh · 2017 · BioMed Research International
The microRNA‐1908 up‐regulation in the peripheral blood cells impairs amyloid clearance by targeting ApoE
Zhibo Wang, W. Qin, Cuibai Wei, Yi Tang, Lina Zhao, H.M. Jin, Y. Li, Q. Wang, Xiaoqian Luan, Jincai He et al. · 2018 · International Journal of Geriatric Psychiatry
Anti-inflammatory effects of naturally occurring retinoid X receptor agonists isolated from Sophora tonkinensis Gagnep. via retinoid X receptor/liver X receptor heterodimers
Wei Wang, K. Nakashima, T. Hirai, M. Inoue · 2019 · Journal of Natural Medicines
Oxaprozin Analogues as Selective RXR Agonists with Superior Properties and Pharmacokinetics
Simone Schierle, A. Chaikuad, Felix F. Lillich, Xiaomin Ni, Stefano Woltersdorf, Espen Schallmayer, Beatrice Renelt, Riccardo Ronchetti, Stefan Knapp, Ewgenij Proschak et al. · 2021 · Journal of Medicinal Chemistry
The Potential Role of PPARs in the Fetal Origins of Adult Disease
Jun Guo, Jue Wu, Qinyuan He, Mengshu Zhang, Hong Li, Yanping Liu · 2022 · Cells
Differential interaction of Apolipoprotein-E isoforms with insulin receptors modulates brain insulin signaling in mutant human amyloid precursor protein transgenic mice
Chan, Elizabeth S, Chen, Christopher, Cole, Gregory M, Wong, Boon-Seng · 2015 · Scientific Reports
Bexarotene Reduces Blood-Brain Barrier Permeability in Cerebral Ischemia-Reperfusion Injured Rats
Lu Xu, Fang Cao, Feng Xu, Bai‐Cheng He, Zhi Dong · 2015 · PLoS ONE
Regulation of prostaglandin F2α against β amyloid clearance and its inflammation induction through LXR/RXR heterodimer antagonism in microglia
Jingjing Zhuang, Haikun Zhang, Rong Zhou, Lili Chen, Jing Chen, Xu Shen · 2013 · Prostaglandins & Other Lipid Mediators
Modeling, Synthesis, and Biological Evaluation of Potential Retinoid X Receptor (RXR) Selective Agonists: Novel Analogues of 4-[1-(3,5,5,8,8-Pentamethyl-5,6,7,8-tetrahydro-2-naphthyl)ethynyl]benzoic Acid (Bexarotene) and (E)-3-(3-(1,2,3,4-tetrahydro-1,1,4,4,6-pentamethylnaphthalen-7-yl)-4-hydroxyphenyl)acrylic Acid (CD3254)
Peter W. Jurutka, Ichiro Kaneko, Joanna Chensi Yang, Jaskaran S. Bhogal, Johnathon C. Swierski, Christa Tabacaru, Luis A. Montano, Chanh C. Huynh, Rabia A. Jama, Ryan D. Mahelona et al. · 2013 · Journal of Medicinal Chemistry
Light, lipids and photoreceptor survival: live or let die?
Olga Lorena German, Daniela L. Agnolazza, Luis E. Politi, Nora P. Rotstein · 2015 · Photochemical & Photobiological Sciences
ABC Transporters in Neurological Disorders: An Important Gateway for Botanical Compounds Mediated Neuro-Therapeutics
Niraj Kumar Jha, Rohan Kar, Rituraj Niranjan · 2019 · Current Topics in Medicinal Chemistry
Ligand Dependent Switch from RXR Homo- to RXR-NURR1 Heterodimerization
Marcel Scheepstra, Sebastian A. Andrei, Rens M. J. M. de Vries, Femke A. Meijer, Jian‐Nong Ma, Ethan S. Burstein, Roger Olsson, Christian Ottmann, L.‐G. Milroy, Luc Brunsveld · 2017 · ACS Chemical Neuroscience
Genome-Wide Screen of the Hippocampus in Aged Rats Identifies Mitochondria, Metabolism and Aging Processes Implicated in Sevoflurane Anesthesia
Yujie Wang, Min Qian, Yinyin Qu, Ning Yang, Bing Mu, Kaixi Liu, Jing Yang, Yang Zhou, Cheng Ni, Jing Zhong et al. · 2020 · Frontiers in Aging Neuroscience
Photoaffinity Labeling and Quantitative Chemical Proteomics Identify LXRβ as the Functional Target of Enhancers of Astrocytic apoE
Uthpala I. Seneviratne, Zhen Huang, Christopher W. am Ende, Todd W. Butler, Leah Cleary, Erica C. Dresselhaus, Edelweiss Evrard, Ethan L. Fisher, Michael E. Green, Christopher J. Helal et al. · 2020 · Cell chemical biology
Factors Influencing Alzheimer’s Disease Risk: Whether and How They are Related to the APOE Genotype
Rong Zhang, Xiaojiao Xu, Hang Yu, Xiaolong Xu, Manli Wang, Weidong Le · 2022 · Neuroscience Bulletin
Transporters as Drug Targets in Neurological Diseases
Hisham Qosa, L. Mohamed, Saeed Alqahtani, Bilal Abuasal, RA Hill, Amal Kaddoumi · 2016 · Clinical Pharmacology & Therapeutics
A Toxic Conformer of Aβ42 with a Turn at 22–23 is a Novel Therapeutic Target for Alzheimer’s Disease
Naotaka Izuo, Chihiro Kasahara, Kazuma Murakami, Toshiaki Kume, Masahiro Maeda, Kazuhiro Irie, Koutaro Yokote, Takahiko Shimizu · 2017 · Scientific Reports
Inflammatory Cyclooxygenase Activity and PGE2 Signaling in Models of Alzheimer’s Disease
Jenny U. Johansson, Nathaniel S. Woodling, Ju Shi, Katrin I. Andreasson · 2015 · Current Immunology Reviews
Increased Tau Phosphorylation and Impaired Presynaptic Function in Hypertriglyceridemic ApoB-100 Transgenic Mice
Nikolett Lénárt, Viktor Szegedi, Gábor Juhász, Aniko Kasztner, János Horváth, Erika Bereczki, Melinda E. Tóth, Botond Penke, Miklós Sántha · 2012 · PLoS ONE
Combined treatment with bexarotene and rosuvastatin reduces angiotensin‐ II ‐induced abdominal aortic aneurysm in apo E −/− mice and angiogenesis
P. Escudero, A Navarro, Carlos Ferrando, Elena Furió, Herminia González Navarro, Marina Juez, María‐Jesús Sanz, Laura Piqueras · 2015 · British Journal of Pharmacology
Correction: A Novel Retro-Inverso Peptide Inhibitor Reduces Amyloid Deposition, Oxidation and Inflammation and Stimulates Neurogenesis in the APPswe/PS1ΔE9 Mouse Model of Alzheimer’s Disease
Vadivel Parthsarathy, Paula L. McClean, Christian HÃ¶lscher, Mark Taylor, Claire L. Tinker, Glynn Jones, Oleg Kolosov, Elisa Salvati, Maria Gregori, Massimo Masserini et al. · 2013 · PLoS ONE
The cell type resolved mouse transcriptome in neuron-enriched brain tissues from the hippocampus and cerebellum during prion disease
Anna Majer, Sarah J. Medina, Debra Sorensen, Matthew J. Martin, Kathy L. Frost, Clark S. Phillipson, Kathy Manguiat, Stephanie A. Booth · 2019 · Scientific Reports
Molecular pathophysiology of diabetes mellitus during pregnancy with antenatal complications
Arthur Tigranovich Kopylov, О.В. Папышева, Iveta Gribova, Galina Kotaysch, Л. А. Харитонова, Tatiana Mayatskaya, Ekaterina Sokerina, Anna L. Kaysheva, S. Morozov · 2020 · Scientific Reports
Strategies to gain novel Alzheimer’s disease diagnostics and therapeutics using modulators of ABCA transporters
Jens Pahnke, Pablo Bascuñana, Mirjam Brackhan, Katja Stefan, Vigneshwaran Namasivayam, Radosveta P. Koldamova, Jingyun Wu, Luisa Möhle, Sven Marcel Stefan · 2021 · Free Neuropathology
Emerging therapeutics agents and recent advances in drug repurposing for Alzheimer’s disease
Neha Neha, Suhel Parvez · 2022 · Ageing Research Reviews
The novel function of bexarotene for neurological diseases
Yangtao Liu, Pengwei Wang, Guofang Jin, Peijie Shi, Yonghui Zhao, Jiayi Guo, Yaling Yin, Qian-Hang Shao, Peng Li, Pengfei Yang · 2023 · Ageing Research Reviews
(−)-Meptazinol–melatonin hybrids as novel dual inhibitors of cholinesterases and amyloid-β aggregation with high antioxidant potency for Alzheimer’s therapy
Shaobing Cheng, Wei Zheng, Ping Gong, Qiang Zhou, Qiong Xie, Lining Yu, Peiyi Zhang, Liangkang Chen, Juan Li, Jianxing Chen et al. · 2015 · Bioorganic & Medicinal Chemistry
Correlation of Aβ oligomer levels in matched cerebrospinal fluid and serum samples
Takashi Kasai, Takahiko Tokuda, Mark Taylor, Masaki Kondo, David M. A. Mann, Penelope G. Foulds, Masanori Nakagawa, David Allsop · 2013 · Neuroscience Letters
Effects of NR1H3 Genetic Variation on the Expression of Liver X Receptor α and the Progression of Alzheimer's Disease
Teemu Natunen, Henna Martiskainen, Timo Sarajärvi, Seppo Helisalmi, Juha‐Pekka Pursiheimo, Jayashree Viswanathan, Marjo H. Laitinen, Petra M. Mäkinen, Tarja Kauppinen, Tuomas H. Rauramaa et al. · 2013 · PLoS ONE
Analysis of differential secondary effects of novel rexinoids: select rexinoid X receptor ligands demonstrate differentiated side effect profiles
Pamela A. Marshall, Peter W. Jurutka, Carl E. Wagner, Arjan van der Vaart, Ichiro Kaneko, Pedro I. Chavez, Ning Ma, Jaskaran S. Bhogal, Pritika H. Shahani, Johnathon C. Swierski et al. · 2015 · Pharmacology Research & Perspectives
Regulation of the Postsynaptic Compartment of Excitatory Synapses by the Actin Cytoskeleton in Health and Its Disruption in Disease
Holly Stefen, Chanchanok Chaichim, John Power, Thomas Fath · 2016 · Neural Plasticity
New Genes and New Insights from Old Genes
John Matthew Ringman, Giovanni Coppola · 2013 · CONTINUUM Lifelong Learning in Neurology
Text mining-based in silico drug discovery in oral mucositis caused by high-dose cancer therapy
Jon Kirk, Nirav P. Shah, Braxton D. Noll, Craig B. Stevens, Marshall Lawler, Farah Bahrani Mougeot, Jean-Luc Mougeot · 2018 · Supportive Care in Cancer
Memory Enhancement and Deep-Brain Stimulation of the Entorhinal Area
Katsuhiro Kobayashi, Harumi Yoshinaga, Yoko Ohtsuka · 2012 · New England Journal of Medicine
Exomeres and supermeres: Current advances and perspectives
Li Yu, Hui Shi, Tingxin Gao, Wenrong Xu, Hui Qian, Jiajia Jiang, Xiao Yang, Xingdong Zhang · 2025 · Bioactive Materials
Infectivity versus Seeding in Neurodegenerative Diseases Sharing a Prion-Like Mechanism
Natalia Fernández‐Borges, Hasier Eraña, Saioa R. Elezgarai, Chafik Harrathi, Mayela Gayosso, Joaquı́n Castilla · 2013 · International Journal of Cell Biology
Small molecule LX2343 ameliorates cognitive deficits in AD model mice by targeting both amyloid β production and clearance
Xiaodan Guo, Guanglong Sun, Tingting Zhou, Xin Xu, Zhiyuan Zhu, Vatcharin Rukachaisirikul, Lihong Hu, Xu Shen · 2016 · Acta Pharmacologica Sinica
Bexarotene Does Not Clear Amyloid Beta Plaques but Delays Fibril Growth: Molecular Mechanisms
Pham Dinh Quoc Huy, Nguyen Quoc Thai, Zuzana Bednáriková, Le Huu Phuc, Huynh Quang Linh, Zuzana Gažová, Mai Suan Li · 2017 · ACS Chemical Neuroscience
Upstream lipid and metabolic systems are potential causes of Alzheimer's disease, Parkinson's disease and dementias
Oliver Cooper, Penelope J. Hallett, Ole Isacson A · 2022 · FEBS Journal
A novel AD theranostic platform with NIR-II laser controlled drug release and real-time monitoring of therapeutic outcomes
Zhili Qiu, Guojun Cao, Shanrong Lv, Dehong Yu, Jingjing Fu, Hanrong Yan, Yuting Li, Peng Zhou, Xiunan Wu, Zhao Liu et al. · 2023 · Chemical Engineering Journal
Advances in drug design with RXR modulators
Belén Vaz, Ángel R. de Lera · 2012 · Expert Opinion on Drug Discovery
Odor-Induced Neuronal Rhythms in the Olfactory Bulb Are Profoundly Modified in ob/ob Obese Mice
Yan Chelminski, Chr̀istophe Magnan, Serge H. Luquet, Amandine Everard, Nicolas Meunier, Hirac Gurden, Claire Martin · 2017 · Frontiers in Physiology
Liver X receptor agonist treatment significantly affects phenotype and transcriptome of APOE3 and APOE4 Abca1 haplo-deficient mice
Alexis Y. Carter, Florent Letronne, Nicholas Francis Fitz, Anaïs Mounier, Cody M. Wolfe, Kyong Nyon Nam, Valerie L. Reeves, Hafsa Kamboh, Iliya M. Lefterov, Radosveta P. Koldamova · 2017 · PLoS ONE
Aplysinellamides A–C, Bromotyrosine-Derived Metabolites from an Australian Aplysinella sp. Marine Sponge
Liwen Tian, Yunjiang Feng, Yoko Shimizu, Tom A. Pfeifer, Cheryl Lea Wellington, John N. A. Hooper, Ronald J. Quinn · 2014 · Journal of Natural Products
Preclinical data reproducibility for R&D—the challenge for neuroscience
Thomas Steckler · 2015 · Psychopharmacology
Class I HDAC inhibition is a novel pathway for regulating astrocytic apoE secretion
Dresselhaus, Erica, Duerr, James M., Vincent, Fabien, Sylvain, Emily K., Beyna, Mercedes, Lanyon, Lorraine F., LaChapelle, Erik, Pettersson, Martin, Bales, Kelly R., Ramaswamy, Gayathri · 2018 · PLOS ONE
Apolipoprotein E Signals via TLR4 to Induce CXCL5 Secretion by Asthmatic Airway Epithelial Cells
Or Kalchiem‐Dekel, Xianglan Yao, Amisha V. Barochia, Maryann M. Kaler, Debbie M Figueroa, William Karkowsky, Elizabeth M. Gordon, Meixia Gao, Marı́a M. Fergusson, Xuan Qu et al. · 2020 · American Journal of Respiratory Cell and Molecular Biology
Pharmacological Activation of RXR-α Promotes Hematoma Absorption via a PPAR-γ-dependent Pathway After Intracerebral Hemorrhage
Chaoran Xu, Huaijun Chen, Shengjun Zhou, Chenjun Sun, Xiaolong Xia, Yucong Peng, Jianfeng Zhuang, Xiongjie Fu, Hanhai Zeng, Hang Zhou et al. · 2021 · Neuroscience Bulletin
Understanding the Link Between Maternal Overnutrition, Cardio-Metabolic Dysfunction and Cognitive Aging
Daria Peleg‐Raibstein · 2021 · Frontiers in Neuroscience
Current and Future Nano-Carrier-Based Approaches in the Treatment of Alzheimer’s Disease
Astik Kumar, Sachithra Thazhathuveedu Sudevan, Aathira Sujathan Nair, Ashutosh Kumar Singh, Sunil Kumar, Jobin Jose, Tapan Behl, Sabitha Mangalathillam, Bijo Mathew, Hoon Kim · 2023 · Brain Sciences
Thiazolidinediones Promote Axonal Growth through the Activation of the JNK Pathway
Rodrigo A. Quintanilla, Juan Alejandro Godoy, Iván E. Alfaro, Deny Cabezas-Bratesco, Rommy von Bernhardi M., Miguel Bronfman, Nibaldo C. Inestrosa · 2013 · PLoS ONE
The Ethics of Early Evidence — Preparing for a Possible Breakthrough in Alzheimer's Disease
Justin Lowenthal, Sara Chandros Hull, Steven D. Pearson · 2012 · New England Journal of Medicine
Improving the predictive value of interventional animal models data
Caroline J. Zeiss · 2014 · Drug Discovery Today
Synthesis and Identification of New Flavonoids Targeting Liver X Receptor β Involved Pathway as Potential Facilitators of Aβ Clearance with Reduced Lipid Accumulation
Yun Hu, Yaqi Yang, Yanjun Yu, Gesi Wen, Nana Shang, Wei Zhuang, Dihan Lu, Binhua Zhou, Baoxia Liang, Xin Yue et al. · 2013 · Journal of Medicinal Chemistry
Remyelinating strategies in multiple sclerosis
Felix Luessi, Tanja Kuhlmann, Frauke Zipp · 2014 · Expert Review of Neurotherapeutics
Modeling, Synthesis and Biological Evaluation of Potential Retinoid X Receptor‐Selective Agonists: Novel Halogenated Analogues of 4‐[1‐(3,5,5,8,8‐Pentamethyl‐5,6,7,8‐tetrahydro‐2‐naphthyl)ethynyl]benzoic Acid (Bexarotene)
Julie K. Furmick, Ichiro Kaneko, Angela N. Walsh, Joanna Chensi Yang, Jaskaran S. Bhogal, Geoffrey M. Gray, Juan C. Baso, Drew O. Browder, Jessica L. S. Prentice, Luis A. Montano et al. · 2012 · ChemMedChem
Nuclear retinoid receptors and pregnancy: placental transfer, functions, and pharmacological aspects
Aurélie Comptour, Marion Rouzaire, Corinne Belville, Damien Bouvier, Denis Gallot, Loı̈c Blanchon, Vincent Sapin · 2016 · Cellular and Molecular Life Sciences
CSF ApoE predicts clinical progression in nondemented APOEε4 carriers
Argonde C. van Harten, Wesley Jongbloed, Charlotte Elisabeth Teunissen, Philip Scheltens, Robert Veerhuis, Wiesje M. van der Flier · 2017 · Neurobiology of Aging
5-HT3 Antagonist Ondansetron Increases apoE Secretion by Modulating the LXR-ABCA1 Pathway
Motoko Shinohara, Mitsuru Shinohara, Jing Zhao, Yuan Fu, Chia‐Chen Liu, Takahisa Kanekiyo, Guojun Bu · 2019 · International Journal of Molecular Sciences
New Hope from an Old Drug: Fighting Alzheimer's Disease with the Cancer Drug Bexarotene (Targretin)?
Giorgio Aicardi · 2013 · Rejuvenation Research
MicroRNAs in brain cholesterol metabolism and their implications for Alzheimer's disease
Yoon, Hyejin, Flores, Luis F., Kim, Jungsu · 2016 · Biochimica et Biophysica Acta (BBA) - Molecular and Cell Biology of Lipids
Carotenoid Supplementation for Alleviating the Symptoms of Alzheimer’s Disease
Jolanta Flieger, Alicja Forma, Wojciech Flieger, Michał Flieger, Piotr J. Gawlik, Eliasz Dzierżyński, Ryszard Maciejewski, Grzegorz Teresiński, Jacek Baj · 2024 · International Journal of Molecular Sciences
Multilocus genetic profiling to empower drug trials and predict brain atrophy
Omid Kohannim A, Xue Hua, Priya Rajagopalan, Derrek P. Hibar, Neda Jahanshad, Joshua D. Grill, Liana G. Apostolova, Arthur W. Toga, Clifford R. Jack, Michael Walter Weiner et al. · 2013 · NeuroImage Clinical
Treatment implications of the altered cytokine-insulin axis in neurodegenerative disease
Ian Albert Clark, Bryce Vissel · 2013 · Biochemical Pharmacology
Influence of Imidazole-Dipeptides on Cognitive Status and Preservation in Elders: A Narrative Review
Nobutaka Masuoka, Chenxu Lei, Haowei Li, Tatsuhiro Hisatsune · 2021 · Nutrients
Potential therapeutic uses of rexinoids
Ana S. Leal, Lyndsey A. Reich, Jessica A. Moerland, Di Zhang, Karen T. Liby · 2021 · Advances in pharmacology
A breach in the blood–brain barrier
Peter Carmeliet, Bart De Strooper · 2012 · Nature
Age-related neuropsychiatric symptoms in presenilins conditional double knockout mice
Yan Li, Li Li, Wenfei Han, Boxi Pan, Xiaolin Xue, Bing Mei · 2013 · Brain Research Bulletin
RXR Partial Agonist Produced by Side Chain Repositioning of Alkoxy RXR Full Agonist Retains Antitype 2 Diabetes Activity without the Adverse Effects
Kohei Kawata, Ken‐ichi Morishita, Mariko Nakayama, Shoya Yamada, Toshiki Kobayashi, Yuki Furusawa, Sakae Arimoto‐Kobayashi, Toshitaka Oohashi, Makoto Makishima, Hirotaka Naitou et al. · 2014 · Journal of Medicinal Chemistry